U.S. Company Recieves Approval To Revive The Dead
A group of scientist, standing beside an operating table, machines chirping and ventilators pumping. Slowly a doctor sinks a long needle, filled with cells and chemicals, into the brain-stem of a brain-dead patient, with the hopes of reactivating their brain and bring them back to life. No, it’s not a scene out of Frankenstein. It will soon be a reality. Bioquark, a U.S. biotech company, has been granted permission by a review board to begin human trials in both the U.S. and and India. The company will start with 20 brain-dead patients for their highly controversial study, known as the ReAnima project, beginning next year. Dr. Calixto Machado, a member of the American Academy of Neurology, is a well known neurological researcher, will be one of the doctors on the team. Their “subjects” have all been medically certified as being brain dead, meaning that the only thing keeping their bodies alive are life support machines. Their spinal cords will be
Continue reading →